Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Thirunavukkarasu Sathish, Robyn Tapp, Mark E. Cooper, Paul Zimmet

    Research output: Contribution to journalComment/debatepeer-review

    14 Citations (Scopus)

    Abstract

    The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.
    Original languageEnglish
    Article number101204
    JournalDiabetes and Metabolism
    Volume47
    Issue number2
    Early online date28 Oct 2020
    DOIs
    Publication statusPublished - Mar 2021

    Keywords

    • COVID-19
    • Coronavirus
    • Incident diabetes
    • Inflammation
    • Insulin resistance
    • Insulin secretion
    • New-onset diabetes
    • Metabolism
    • Type 1 diabetes
    • Type 2 diabetes

    ASJC Scopus subject areas

    • Endocrinology
    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism

    Fingerprint

    Dive into the research topics of 'Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes'. Together they form a unique fingerprint.

    Cite this